COVID-19
Pfizer and BioNTech’s two-dose novel coronavirus (COVID-19) vaccine showed 100 percent efficacy and robust antibody responses in adolescents
… Read MoreThe Pfizer and BioNTech and Moderna novel coronavirus (COVID-19) vaccinations are 90 percent effective at reducing infections in fully vaccinated
… Read MoreInsomnia, disrupted sleep, and daily burnout are linked to a heightened risk of not only becoming infected with the novel coronavirus (COVID-19), but
… Read MoreA new study published in the Journal of General Internal Medicine compared the impact of the novel coronavirus (COVID-19) on patients and hospital
… Read MoreIn a new retrospective study at the University of Chicago Medicine published in JAMA Network Open of individuals tested for the novel coronavirus
… Read MoreThe novel coronavirus (COVID-19) pandemic has taken the lives of millions of people around the world but has also left hundreds with lingering
… Read MoreThe AstraZeneca novel coronavirus (COVID-19) vaccine candidate, AZD1222, demonstrated 79 percent efficacy at preventing symptomatic COVID-19 and 100
… Read More
SHARE